Phase 1 Central Nervous System Diseases Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

NeoplasmsNeoplasms by SiteBrain Diseases+30 more

M.D. Anderson Cancer Center24 enrolled3 locationsNCT03911388

Recruiting

Phase 1Phase 2

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

Breast NeoplasmsBreast DiseasesNeoplasms+5 more

Stemline Therapeutics, Inc.73 enrolled86 locationsNCT05386108

Recruiting

Phase 1

NG004 in Spinal Cord Injury Patients

Central Nervous System DiseasesNervous System DiseasesTrauma, Nervous System+4 more

NovaGo Therapeutics AG21 enrolled6 locationsNCT06817577